DJIA 16,399.67 19.26 0.12%
NASDAQ 4,316.07 57.64 1.35%
S&P 500 1,904.01 17.25 0.91%
market minute promo

SPDR S&P Biotech (ETF) (NYSEMKT: XBI)

158.94 2.86 (1.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

XBI $158.94 1.83%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $156.47
Previous Close $156.08
Daily Range $155.70 - $160.25
52-Week Range $114.12 - $172.52
Market Cap $1.3B
Dividend (Yield) $2.25 (1.0%)
Volume 284,035
Average Daily Volume 476,176

News & Commentary

1 of These 3 Cratering Biotechs Is a Buy

Biotech stocks have been performing poorly in general this year. However, some biotechs have been having a truly terrible year. Here's a look at the three worst-performing biotechs and their respective chances at making a comeback.

Evaluating The Best Biotech ETF Options

Best And Worst ETFs Of The Week Amid Market Rebound

Best And Worst ETFs Of The Week Amid Market Rebound

Monday's ETF Movers: ILF, XBI

The Complete Guide to Biotech ETFs - ETF News And Commentary

The Complete Guide to Biotech ETFs - ETF News And Commentary

Wednesday's ETF Movers: XBI, GDXJ

BioShares Plans Two Innovative Biotech ETFs - ETF News And Commentary

Choice Healthcare ETFs For Growing The Retirement Portfolio

Is Akorn, Inc. An Easy Buy This Week?

Wednesday's ETF Movers: XBI, GDXJ

See More XBI News...

Sector

Sector Equity

Industry

Health/Biotechnology Funds

SPDR S&P Biotech (ETF) (XBI) Description

The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index. Website: http://www.spdrs.com/